North American Prodromal Synucleinopathy Consortium
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Aug 6, 2018
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
REM sleep behavior disorder (RBD) is a rare disorder where people act out their dreams. People with RBD often, but not always, develop Parkinson's Disease, dementia with Lewy bodies, multiple system atrophy, or other neurodegenerative diseases of the synucleinopathy type. The North American Prodromal Synucleinopathy (NAPS) Consortium was formed with the purpose of enrolling participants with RBD, in anticipation of a future clinical trial of a neuroprotective treatment against synucleinopathies. The NAPS Consortium will collect standardized clinical assessments, biofluids, and other data in...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Idiopathic REM sleep behavior disorder
- Exclusion Criteria:
- • REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc)
- • Other neurological disorder
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Minneapolis, Minnesota, United States
Boston, Massachusetts, United States
Atlanta, Georgia, United States
Portland, Oregon, United States
Los Angeles, California, United States
Redwood City, California, United States
Saint Louis, Missouri, United States
Sun City, Arizona, United States
Montréal, Quebec, Canada
Patients applied
Trial Officials
Yo-El Ju, MD
Principal Investigator
Washington University School of Medicine
Bradley Boeve, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials